Sr Manager Market Access at Eli Lilly and Company

Toronto, Ontario, Canada

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree or higher required, ideally in a scientific field
Significant pharmaceutical industry experience
Minimum 5 years of experience in market access and/or related functions (e.g. HEOR)
In-depth knowledge of CDA-AMC, INESSS, pCPA and Product Listing Agreements processes
Strong Commercial/business background an asset
Ability to work well cross-functionally
Outstanding strategic thinking skills—proven ability to identify/define business questions and issues, synthesize information from multiple sources, conduct analysis, formulate actionable recommendations
High-energy, self-starter that is assertive, possesses a high degree of self-confidence and intellectual curiosity, exhibits a bias for action and demonstrates good executive presence
Energized by working with ambiguity and complexity
Ability to think creatively in developing and implementing business solutions
High degree of initiative and sense of urgency

Responsibilities

Lead the development and delivery of market access strategies, including pre-launch planning, portfolio assessment and CDA-AMC/INESSS, provincial and private payer submissions
Oversee cross-functional development and execution of payer solutions and evidence generation to support reimbursement objectives
Develop business cases in partnership with Pricing / Commercial / Finance teams to communicate strategies and approve prices with local and global leadership
In collaboration with Pricing and Regional Market Access Team, support the development of pCPA negotiation strategies
Develop value dossiers for national and regional Health Technology Assessment (HTA) bodies and payers (public and private)
Lead the planning and development of sound health economic arguments, including robust pharmacoeconomic modeling and budget impact analyses
Operate as a key member of the commercial core teams and be a role model for cross-functional working to ensure therapeutic area objectives are met
Cultivate partnerships with the global organization to understand and support the market access needs of the business in Canada

Skills

Key technologies and capabilities for this role

Market AccessPricing StrategyReimbursement StrategyHealth Technology AssessmentHTAPayer ContractingValue PropositionValue DossierBusiness Case Development

Questions & Answers

Common questions about this position

What is the work arrangement for this role?

This is a head office role classified as a flexible worker, requiring on-site presence in the Toronto office for 10 days or more per month (or greater than or equal to 50% of the time), as determined by your manager and business needs.

What is the salary for this position?

This information is not specified in the job description.

What are the key responsibilities of this role?

The role involves leading market access strategies, developing price and reimbursement strategies, creating value dossiers for HTA agencies and payers, overseeing payer solutions and evidence generation, and collaborating with cross-functional teams.

What is the company culture like at Eli Lilly?

Eli Lilly unites caring with discovery to make life better for people around the world, puts people first, and emphasizes giving best effort to work while fostering determination to improve lives globally.

Who does this role report to and what collaboration is expected?

The role reports to the Vice President, Pricing and Market Access, and requires close collaboration with cross-functional teams including Regional Market Access, Pricing, Commercial, Finance, and commercial core teams.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free